Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

  • STATUS
    Recruiting
  • participants needed
    726
  • sponsor
    Egyptian Center for Research and Regenerative Medicine
Send
Updated on 19 February 2024
See if I qualify
fever
dyspnea
cough
covid-19
SARS
respiratory symptom
coronavirus infection
acute respiratory syndrome (sars)

Summary

The medical and paramedical staff of the front-line services are potentially exposed to SARS-CoV-2. Therefore, despite the application of standard protective measures, it is possible that a certain number of these personnel have already contracted SARS-CoV-2, including in its asymptomatic form. Serological testing in this context would be useful for deploying immune healthcare workers as to limit the risk of viral infection and transmission. Therefore, it is of utmost importance to prove that the serological response entails the production of neutralizing antibodies.

Details
Condition COVID, Corona Virus Infection
Age 18years - 60years
Treatment Specific anti-SARS-CoV-2 antibodies
Clinical Study IdentifierNCT04424017
SponsorEgyptian Center for Research and Regenerative Medicine
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Not previously diagnosed with COVID-19 except for convalescents
Not currently symptomatic with fever or respiratory symptoms (cough, dyspnea)

Exclusion Criteria

Patients with fever or respiratory symptoms (cough, dyspnea)
Refusal to give informed consent, or contraindication to venipuncture
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

fever
dyspnea
cough
covid-19
SARS
respiratory symptom
coronavirus infection
acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.